Advantage Alpha Capital Partners’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$385K	Sell	6,972 -1,662	-19%	-$91.9K	0.1%	106
2025 Q1	$418K	Buy	8,634 +2,892	+50%	+$140K	0.1%	100
2024 Q4	$222K	Sell	5,742 -5,594	-49%	-$216K	0.05%	144
2024 Q3	$510K	Buy	+11,336	New	+$510K	0.12%	117